Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Mar;1(2):155–159. doi: 10.1128/cdli.1.2.155-159.1994

Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1.

J Matsuda 1, M Gotoh 1, K Gohchi 1, M Tsukamoto 1, N Saitoh 1, T Kinoshita 1
PMCID: PMC368219  PMID: 7496937

Abstract

We measured serum 2,5-oligoadenylate synthetase (2,5-AS) levels and soluble interleukin-2 receptor (sIL-2R) levels in human immune deficiency virus type 1 (HIV-1)-positive and HIV-1-negative hemophiliacs in order to clarify the clinical significance of these parameters in hemophiliacs. Serum 2,5-AS levels were measured by a radioimmunosorbent assay, and sIL-2R levels were measured by an enzyme-linked immunosorbent assay. The mean serum 2,5-AS levels were higher in AIDS-related-complex and AIDS patients, asymptomatic carriers, and HIV-1-negative hemophiliacs than in hepatitis C virus-positive patients and healthy controls. Serial determinations showed that the 2,5-AS levels tended to increase in HIV-1-positive patients, especially those with AIDS-related complex or AIDS, although it showed a substantial decrease in the terminal stage. The serum sIL-2R levels were higher in HIV-1-positive patients, HIV-1-negative patients, and hepatitis C virus-positive patients than in controls. Serial studies showed little change in the HIV-1-positive and HIV-1-negative groups, although sIL-2R levels showed a tendency to decrease with zidovudine treatment. On the basis of the present results, we may well conclude that 2,5-AS and sIL-2R are not specific markers for hemophiliacs with HIV-1 infection. However, serial measurement of these markers can still be useful for assessing the progression of AIDS and the prognosis for patients with AIDS, as well as for monitoring the response to zidovudine.

Full text

PDF
155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cuthbert R. J., Ludlam C. A., Steel C. M., Beatson D., Peutherer J. F. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy. Br J Haematol. 1992 Mar;80(3):364–369. doi: 10.1111/j.1365-2141.1992.tb08146.x. [DOI] [PubMed] [Google Scholar]
  2. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  3. Galli M., Ridolfo A. L., Balotta C., Riva A., Cocchi F., Musicco M., Albarello V., Moroni M. Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine. AIDS. 1991 Oct;5(10):1231–1235. doi: 10.1097/00002030-199110000-00012. [DOI] [PubMed] [Google Scholar]
  4. Gascón P., Zoumbos N. C., Young N. S. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med. 1984 Feb;100(2):173–177. doi: 10.7326/0003-4819-100-2-173. [DOI] [PubMed] [Google Scholar]
  5. Greene W. C., Leonard W. J., Depper J. M., Nelson D. L., Waldmann T. A. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med. 1986 Oct;105(4):560–572. doi: 10.7326/0003-4819-105-4-560. [DOI] [PubMed] [Google Scholar]
  6. Kimberly R. P., Inman R. D., Bussel J. B., Polk J. R., Hilgartner M. W. Modulation of mononuclear phagocyte system function and circulating immune complexes by lyophilized concentrates in patients with classic hemophilia. Clin Immunol Immunopathol. 1984 Jun;31(3):321–330. doi: 10.1016/0090-1229(84)90085-0. [DOI] [PubMed] [Google Scholar]
  7. Lengyel P. Biochemistry of interferons and their actions. Annu Rev Biochem. 1982;51:251–282. doi: 10.1146/annurev.bi.51.070182.001343. [DOI] [PubMed] [Google Scholar]
  8. Matsuda J., Gohchi K., Hama H., Tsukamoto M., Saitoh N., Kinoshita T. High prevalence of anti-cardiolipin antibody, C1q-, C3d-, and mRF-IgG immune complexes, and anti-nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr. 1993 Oct;6(10):1120–1124. [PubMed] [Google Scholar]
  9. Matsuda J., Tsukamoto M., Gohchi K., Saitoh N., Kawasugi K., Kinoshita T. Serum adenosine deaminase 2 and neopterin levels are increased in a majority of hemophiliacs irrespective of infection with human immunodeficiency virus type 1. Clin Infect Dis. 1993 Feb;16(2):260–264. doi: 10.1093/clind/16.2.260. [DOI] [PubMed] [Google Scholar]
  10. Noronha I. L., Daniel V., Schimpf K., Opelz G. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV. Clin Exp Immunol. 1992 Feb;87(2):287–292. doi: 10.1111/j.1365-2249.1992.tb02989.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Annu Rev Biochem. 1987;56:727–777. doi: 10.1146/annurev.bi.56.070187.003455. [DOI] [PubMed] [Google Scholar]
  12. Preble O. T., Rook A. H., Steis R., Silverman R. H., Krause D., Quinnan G. V., Masur H., Jacob J., Longo D., Gelmann E. P. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome. J Infect Dis. 1985 Sep;152(3):457–465. doi: 10.1093/infdis/152.3.457. [DOI] [PubMed] [Google Scholar]
  13. Preble O. T., Rothko K., Klippel J. H., Friedman R. M., Johnston M. I. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med. 1983 Jun 1;157(6):2140–2146. doi: 10.1084/jem.157.6.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Prince H. E., Kleinman S., Williams A. E. Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol. 1988 Feb 15;140(4):1139–1141. [PubMed] [Google Scholar]
  15. Read S. E., Williams B. R., Coates R. A., Evans W. K., Fanning M. M., Garvey M. B., Shepherd F. A. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome. J Infect Dis. 1985 Sep;152(3):466–472. doi: 10.1093/infdis/152.3.466. [DOI] [PubMed] [Google Scholar]
  16. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  17. Rubin L. A. The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum. 1990 Aug;33(8):1145–1148. doi: 10.1002/art.1780330814. [DOI] [PubMed] [Google Scholar]
  18. Sawai H., Ishibashi K., Itoh M., Watanabe S. 2',5'-Oligoadenylate and 2',5'-oligoadenylate phosphodiesterase in human plasma. Biochem Biophys Res Commun. 1984 Dec 28;125(3):1061–1066. doi: 10.1016/0006-291x(84)91391-3. [DOI] [PubMed] [Google Scholar]
  19. Schröder H. C., Suhadolnik R. J., Pfleiderer W., Charubala R., Müller W. E. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection. Int J Biochem. 1992;24(1):55–63. doi: 10.1016/0020-711x(92)90229-t. [DOI] [PubMed] [Google Scholar]
  20. Scott-Algara D., Vuillier F., Marasescu M., de Saint Martin J., Dighiero G. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients. AIDS Res Hum Retroviruses. 1991 Apr;7(4):381–386. doi: 10.1089/aid.1991.7.381. [DOI] [PubMed] [Google Scholar]
  21. Simmonds P., Beatson D., Cuthbert R. J., Watson H., Reynolds B., Peutherer J. F., Parry J. V., Ludlam C. A., Steel C. M. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet. 1991 Nov 9;338(8776):1159–1163. doi: 10.1016/0140-6736(91)92029-2. [DOI] [PubMed] [Google Scholar]
  22. Watson H. G., Ludlam C. A. Immunological abnormalities in haemophiliacs. Blood Rev. 1992 Mar;6(1):26–33. doi: 10.1016/0268-960x(92)90005-b. [DOI] [PubMed] [Google Scholar]
  23. Witt P. L., Spear G. T., Lindstrom M. J., Kessler H. A., Borden E. C., Phair J., Landay A. L. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. AIDS. 1991 Mar;5(3):289–293. doi: 10.1097/00002030-199103000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES